Seres Therapeutics, Inc.(MCRB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MCRB Seres Therapeutics, Inc.

已收盘 05-29 16:00:00 EDT

0.9217

-0.0078

-0.84%

盘后0.9600

+0.0383+4.16%

19:56 EDT

最高0.9570	最低0.9100	成交量100.48万
今开0.9310	昨收0.9295	日振幅5.06%
总市值1.40亿	流通市值1.10亿	总股本1.51亿
成交额93.28万	换手率0.84%	流通股本1.20亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"MCRB","market":"US","secType":"STK","nameCN":"Seres Therapeutics, Inc.","latestPrice":0.9217,"timestamp":1717012800000,"preClose":0.9295,"halted":0,"volume":1004753,"hourTrading":{"tag":"盘后","latestPrice":0.96,"preClose":0.9217,"latestTime":"19:56 EDT","volume":24387,"amount":22435.9623,"timestamp":1717026975875},"delay":0,"floatShares":119552530,"shares":151447763,"eps":-0.622877,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.0078,"latestTime":"05-29 16:00:00 EDT","open":0.931,"high":0.957,"low":0.91,"amount":932811.2785458,"amplitude":0.050565,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.622877,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1717056000000},"adr":0,"listingDate":1435291200000,"adjPreClose":0.9295,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":0.94,"preClose":0.9295,"latestTime":"09:27 EDT","volume":4515,"amount":4262.5767345,"timestamp":1716989270018},"postHourTrading":{"tag":"盘后","latestPrice":0.96,"preClose":0.9217,"latestTime":"19:56 EDT","volume":24387,"amount":22435.9623,"timestamp":1717026975875},"volumeRatio":0.48594},"requestUrl":"/m/hq/s/MCRB/wiki","defaultTab":"wiki","newsList":[{"id":"2434404841","title":"奥本海默：维持Seres Therapeutics(MCRB.US)评级，由优于大市调整至优于大市评级, 目标价由5.00美元调整至4.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2434404841","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2434404841?lang=zh_cn&edition=full","pubTime":"2024-05-10 00:55","pubTimestamp":1715273705,"startTime":"0","endTime":"0","summary":"奥本海默：维持Seres Therapeutics(MCRB.US)评级，由优于大市调整至优于大市评级, 目标价由5.00美元调整至4.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405100055058aed8f4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405100055058aed8f4b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432590892","title":"Seres Therapeutics Inc   预计每股亏损34美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432590892","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432590892?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:46","pubTimestamp":1714743982,"startTime":"0","endTime":"0","summary":"   * Seres Therapeutics Inc    预计将于5月7日公布截至2024年3月31日的财报(，预计)。* 根据 LSEG 的数据，6 位分析师的平均预期显示，这家总部位于马萨诸塞州剑桥市的公司预计将实现 25 万美元的营收。* LSEG 的分析师平均预计 Seres Therapeutics Inc 每股亏损 34 美分。* 华尔街对 Seres Therapeutics Inc 的 12 个月目标价中位数为 7.00 美元，高于其最新收盘价 1.11 美元。5月3日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2417239460","title":"美国研究综述-Arrivent 生物制药公司、弗格森公司、目标公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2417239460","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2417239460?lang=zh_cn&edition=full","pubTime":"2024-03-06 14:48","pubTimestamp":1709707680,"startTime":"0","endTime":"0","summary":"    路透社3月6日 - 华尔街证券分析师周三调整了对 Arrivent Biopharma、Ferguson 和 Target 等几家美国上市公司的评级和目标价。要闻             * Arrivent Biopharma Inc   ：杰富瑞给予买入评级             * 弗格森  ：杰富瑞将目标价从 222 美元上调至 244 美元             * Target Corp   ：汇丰银行将其评级从 \"持有 \"上调至 \"买入\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2416464572","title":"Seres Therapeutics Inc   预计每股亏损50美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2416464572","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2416464572?lang=zh_cn&edition=full","pubTime":"2024-03-01 22:11","pubTimestamp":1709302299,"startTime":"0","endTime":"0","summary":"   * Seres Therapeutics Inc    将于3月5日公布截至2023年12月31日的季度财报，预计该公司的季度收入将出现下降。* 根据LSEG的数据，6位分析师的平均预期显示，这家总部位于马萨诸塞州剑桥市的公司的营收将从去年同期的101万美元下降65.2%，至35万美元。* LSEG 分析师对 Seres Therapeutics Inc 的平均预期是每股亏损 50 美分。* 华尔街对 Seres Therapeutics Inc 的 12 个月目标价中位数为 10.00 美元，高于其最新收盘价 1.14 美元。3月1日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2402371941","title":"BUZZ--美国股票走势-Albemarle、Illumina、Eversource Energy","url":"https://stock-news.laohu8.com/highlight/detail?id=2402371941","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2402371941?lang=zh_cn&edition=full","pubTime":"2024-01-09 23:52","pubTimestamp":1704815550,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      1月9日 - 华尔街主要股指周二下跌，大型股因国债收益率上升而承压，交易商在本周晚些时候发布关键通胀报告之前缩减了提前开始降息的预期。美东时间10:33，道琼斯工业平均指数  下跌0.68%，报37427.22点。标普500指数  下跌0.46%，报4741.82点；纳斯达克综合指数  下跌0.52%，报14766.438点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2402180475","title":"BUZZ-Seres Therapeutics 因细菌感染药物获得 FDA \"快速通道 \"标签而崛起","url":"https://stock-news.laohu8.com/highlight/detail?id=2402180475","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2402180475?lang=zh_cn&edition=full","pubTime":"2024-01-09 21:31","pubTimestamp":1704807109,"startTime":"0","endTime":"0","summary":"    1月9日 - ** 制药商 Seres Therapeutics    股价盘前上涨 21.2% 至 1.90 美元左右** 该公司宣布其细菌感染药物被美国食品和药物管理局指定为 \"快速通道 \"药物 ** 实验性口服药物SER-155旨在预防胃肠道细菌感染和血流感染，并减轻接受干细胞移植患者的一种严重炎症。** 公司表示，SER-155的早期测试研究数据预计将于2024年第三季度公布。** 快速通道是美国食品和药物管理局为治疗严重或危及生命的疾病的药物保留的一种指定，可加快对该药物的审查。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.serestherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0213},{"period":"1month","weight":0.1267},{"period":"3month","weight":-0.1917},{"period":"6month","weight":-0.1063},{"period":"1year","weight":-0.8035},{"period":"ytd","weight":-0.3361}],"compareEarnings":[{"period":"1week","weight":-0.0029},{"period":"1month","weight":0.0424},{"period":"3month","weight":0.0465},{"period":"6month","weight":0.1608},{"period":"1year","weight":0.2614},{"period":"ytd","weight":0.1147}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Seres Therapeutics, Inc.于2010年10月根据特拉华州法律注册成立。该公司是一家商业阶段的微生物组疗法公司，专注于一类新型生物药物的开发和商业化，这些药物旨在通过调节微生物组来治疗疾病，通过将被破坏的微生物组的功能修复到非疾病状态来恢复健康。该公司还在设计微生物组疗法，这些疗法经过优化，可以去定植病原体并调节宿主功能，以减少和预防感染并诱导免疫耐受。","yearOnYearQuotes":[{"month":1,"riseRate":0.222222,"avgChangeRate":-0.019469},{"month":2,"riseRate":0.111111,"avgChangeRate":-0.063465},{"month":3,"riseRate":0.666667,"avgChangeRate":0.013006},{"month":4,"riseRate":0.555556,"avgChangeRate":-0.019346},{"month":5,"riseRate":0.555556,"avgChangeRate":-0.039454},{"month":6,"riseRate":0.5,"avgChangeRate":0.034656},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.16668},{"month":8,"riseRate":0.666667,"avgChangeRate":0.741726},{"month":9,"riseRate":0.555556,"avgChangeRate":-0.001429},{"month":10,"riseRate":0.111111,"avgChangeRate":-0.092946},{"month":11,"riseRate":0.555556,"avgChangeRate":0.077509},{"month":12,"riseRate":0.111111,"avgChangeRate":-0.086666}],"exchange":"NASDAQ","name":"Seres Therapeutics, Inc.","nameEN":"Seres Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Seres Therapeutics, Inc.(MCRB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Seres Therapeutics, Inc.(MCRB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Seres Therapeutics, Inc.,MCRB,Seres Therapeutics, Inc.股票,Seres Therapeutics, Inc.股票老虎,Seres Therapeutics, Inc.股票老虎国际,Seres Therapeutics, Inc.行情,Seres Therapeutics, Inc.股票行情,Seres Therapeutics, Inc.股价,Seres Therapeutics, Inc.股市,Seres Therapeutics, Inc.股票价格,Seres Therapeutics, Inc.股票交易,Seres Therapeutics, Inc.股票购买,Seres Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Seres Therapeutics, Inc.(MCRB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Seres Therapeutics, Inc.(MCRB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}